Ligand-supported purification of the urotensin-II receptor

Molecular Pharmacology
Ann T DuWalter G Thomas

Abstract

A crucial limitation for structural and biophysical analysis of G protein-coupled receptors (GPCRs) is the inherent challenge of purifying and stabilizing these receptors in an active (agonist-bound) conformation. Peptide ligands, such as the vasoactive, cyclic hormone urotensin-II (U-II), may provide new purification tools, via high affinity, pseudo-irreversible binding suitable for ligand-based affinity purification. We show that the U-II receptor (UT) is resistant to desensitization as a result of low phosphorylation and diminished endocytosis. UT also displays an unusual proclivity to remain active with vasoconstriction sustained despite extensive washout of the ligand. To exploit these properties for ligand-supported purification, we modified the U-II ligand by attaching a biotin moiety and spacer arm to the N terminus, creating a novel affinity ligand (Bio-U-II) to interface with streptavidin media. Bio-U-II bound to UT with pharmacological properties analogous to those of the unmodified U-II ligand (high-affinity, pseudo-irreversible binding). The prebinding of Bio-U-II to UT (before exposure to detergent) facilitated specific capture of UT by stabilizing the receptor structure during solubilization with detergent. Solub...Continue Reading

References

Apr 5, 1996·Biochemical and Biophysical Research Communications·J R ZyskM O Thorner
Jun 28, 2000·Archives of Biochemistry and Biophysics·J Santos-Alvarez, V Sánchez-Margalet
Aug 5, 2000·Science·K PalczewskiM Miyano
Jan 31, 2002·Naunyn-Schmiedeberg's Archives of Pharmacology·Valeria CamardaDomenico Regoli
Oct 2, 2004·The Biochemical Journal·Christophe D ProulxRichard Leduc
Dec 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Muriel NoblesAndrew Tinker
Aug 15, 2006·Nature Structural & Molecular Biology·Céline GalésMichel Bouvier
Oct 25, 2006·Proceedings of the National Academy of Sciences of the United States of America·David SalomKrzysztof Palczewski
Sep 11, 2007·Journal of Molecular Biology·Jörg StandfussGebhard F X Schertler
Oct 24, 2007·Nature·Søren G F RasmussenBrian K Kobilka
Dec 25, 2007·Peptides·Christophe D ProulxRichard Leduc
Jan 15, 2008·Proceedings of the National Academy of Sciences of the United States of America·Maria J Serrano-VegaChristopher G Tate
May 16, 2008·Nature·Midori Murakami, Tsutomu Kouyama
Jun 20, 2008·Nature·Jung Hee ParkOliver Peter Ernst
Jul 3, 2008·Nature·Tony WarneGebhard F X Schertler
Jul 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Francesca MagnaniChristopher G Tate
Aug 5, 2008·Combinatorial Chemistry & High Throughput Screening·Mark L ChiuMaria P MacWilliams
Sep 27, 2008·Nature·Patrick ScheererOliver P Ernst
Mar 13, 2009·American Journal of Physiology. Cell Physiology·Gabrielle E CallanderRoss A D Bathgate
May 9, 2009·Journal of Molecular Biology·Yoko ShibataChristopher G Tate
May 19, 2009·Biochemical Pharmacology·Sid Topiol, Michael Sabio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.